Los Angeles Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Los Angeles Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,773	Closed	-$234K	–	1744
2021 Q1	$234K	Sell	9,773 -11,724	-55%	-$218K	﹤0.01%	1503
2020 Q4	$314K	Sell	21,497 -50	-0.2%	-$663	﹤0.01%	1360
2020 Q3	$306K	Buy	21,547 +90	+0.4%	+$1.38K	﹤0.01%	1263
2020 Q2	$316K	Sell	21,457 -50,520	-70%	-$513K	﹤0.01%	1273
2020 Q1	$297K	Sell	71,977 -2,720	-4%	-$12.8K	﹤0.01%	1059
2019 Q4	$359K	Hold	74,697	–	–	﹤0.01%	1088
2019 Q3	$453K	Buy	+74,697	New	+$466K	﹤0.01%	1016
2015 Q2	–	Sell	-10,280	Closed	-$133K	–	1281
2015 Q1	$133K	Buy	+10,280	New	+$134K	﹤0.01%	1182

Los Angeles Capital Management's GNMK Position: Q2 2021 in Review

Los Angeles Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 9,773 shares — an estimated $234K sold.

Los Angeles Capital Management first reported a position in GNMK in Q1 2015 and held it in 8 quarters. The position peaked at $453K in Q3 2019. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Los Angeles Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Los Angeles Capital Management sold 9,773 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $234K.
Los Angeles Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2015 and held it in 8 quarters.
Los Angeles Capital Management's GenMark Diagnostics, Inc position peaked at $453K in Q3 2019.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.